Source: Eur Respir J, 49 (5) 17E4905; 10.1183/13993003.E4905-2017
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
ERJ May Podcast: Acute exacerbations in patients with IPF treated with nintedanib. Eur Respir J, 49 (5) 17E4905; 10.1183/13993003.E4905-2017

Member's Comments

No comment yet.

Related content which might interest you: Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis Source: Eur Respir J, 49 (5) 1601339; 10.1183/13993003.01339-2016 Year: 2017 Cognitive impairment in patients hospitalized with acute COPD exacerbation Source: International Congress 2014 – Physical activity, exercise and physiotherapy in COPD and asthma Year: 2014 Acute exacerbation in COPD: we must do more Source: Eur Respir J 2016; 47: 14-15 Year: 2016 Educational presentation: NIV in chronic COPD patients Source: Annual Congress 2010 - Practical Workshop: "Non-invasive ventilation in COPD patients" Year: 2010 The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – Bronchodilators for asthma and COPD Year: 2014 Effectiveness of indacaterol with or without tiotropium in patients with moderate or severe chronic obstructive pulmonary disease (COPD) - the GOLDEN II study Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014 QVA149 reduces the risk of moderate-to-severe exacerbations compared with open-label tiotropium in patients with severe COPD: The SPARK study Source: International Congress 2014 – Asthma and COPD management Year: 2014 Effectiveness of self-treatment of exacerbations in COPD patients: Two-year follow-up of the COPE-II study Source: International Congress 2014 – Best abstracts in rehabilitation and chronic care (sponsored by MOTEK Medical) Year: 2014 Acute exacerbation of COPD in Emergency Room: just COPD exacerbations? Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Greatest International ANti-infective Trial (GIANT) – the German cohort: moxifloxacin treatment provides short- and long-term benefits in AECB patients Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006 FORWARD: A study of extrafine beclomethasone/formoterol compared with formoterol alone in patients with severe COPD and a history of exacerbations Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Survival in IPF acute exacerbations: The non-steroid approach Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability Source: International Congress 2014 – Markers Year: 2014 Acute exacerbation of COPD patients therapy priorities: A survey study Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care Year: 2021 A trial of beclomethasone/formoterol in COPD using EXACT-PRO to measure exacerbations Source: Eur Respir J 2013; 41: 12-17 Year: 2013 Acute exacerbations of COPD Source: Eur Respir Monogr 2016; 74: 48-65 Year: 2016 A self-treatment programme in patients with COPD: Effectiveness for the reduction of severe exacerbations Source: International Congress 2015 – Latest insights into chronic care Year: 2015